We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
-13.22%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.1B
AUM Growth
-$3.31B
(-16%)
Cap. Flow
-$374M
Cap. Flow
% of AUM
-2.19%
Top 10 Holdings %
Top 10 Hldgs %
19.96%
Holding
1,420
New
91
Increased
417
Reduced
597
Closed
121
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Stock Market ETF
VTI
|
+$69.4M |
| 2 |
Ulta Beauty
ULTA
|
+$54.9M |
| 3 |
Lockheed Martin
LMT
|
+$54M |
| 4 |
Advanced Micro Devices
AMD
|
+$53.7M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$34M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$53M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$52.3M |
| 3 |
Take-Two Interactive
TTWO
|
+$47.9M |
| 4 |
eBay
EBAY
|
+$44.3M |
| 5 |
Cardinal Health
CAH
|
+$35.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.22% |
| 2 | Healthcare | 14.4% |
| 3 | Financials | 10.22% |
| 4 | Consumer Discretionary | 8.43% |
| 5 | Industrials | 7.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HOLX
951
DELISTED
Hologic
HOLX
| $361K | ﹤0.01% |
5,219
-409
| -7% | -$30.4K |
|
952
Hormel Foods
HRL
$14.3B
| $361K | ﹤0.01% |
7,649
-136
| -2% | -$6.79K |
|
953
BioLife Solutions
BLFS
$1.6B
| $360K | ﹤0.01% |
26,131
+247
| +1% | +$3.62K |
|
954
Inogen
INGN
$174M
| $360K | ﹤0.01% |
14,936
-25
| -0.2% | -$664 |
|
955
Universal Health Services
UHS
$9.76B
| $359K | ﹤0.01% |
3,567
-414
| -10% | -$51.8K |
|
956
Pembina Pipeline
PBA
$29B
| $357K | ﹤0.01% |
10,125
| – | – |
|
957
AvalonBay Communities
AVB
$27.2B
| $356K | ﹤0.01% |
1,839
+28
| +2% | +$6.06K |
|
958
Equitable Holdings
EQH
$13.5B
| $355K | ﹤0.01% |
+13,652
| New | +$396K |
|
959
Toyota
TM
$221B
| $355K | ﹤0.01% |
2,307
-279
| -11% | -$46.1K |
|
960
Landstar System
LSTR
$6.35B
| $354K | ﹤0.01% |
2,436
-228
| -9% | -$34K |
|
961
Q2 Holdings
QTWO
$3.8B
| $354K | ﹤0.01% |
9,196
-1,070
| -10% | -$52K |
|
962
Arrowhead Research
ARWR
$11.8B
| $352K | ﹤0.01% |
10,007
| – | – |
|
|
THR
963
DELISTED
Thermon Group Holdings
THR
| $351K | ﹤0.01% |
25,000
| – | – |
|
964
Broadridge
BR
$18.6B
| $350K | ﹤0.01% |
2,463
+693
| +39% | +$101K |
|
|
965
Take-Two Interactive
TTWO
$45.9B
| $348K | ﹤0.01% |
2,852
-376,561
| -99% | -$47.9M |
|
966
Green Plains
GPRE
$1.15B
| $343K | ﹤0.01% |
12,626
+70
| +0.6% | +$2.19K |
|
|
KRTX
967
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $341K | ﹤0.01% |
+2,698
| New | +$310K |
|
968
iShares MSCI USA Momentum Factor ETF
MTUM
$24.4B
| $340K | ﹤0.01% |
2,499
| – | – |
|
969
Embecta
EMBC
$214M
| $338K | ﹤0.01% |
+13,416
| New | +$387K |
|
970
ESCO Technologies
ESE
$8.16B
| $336K | ﹤0.01% |
4,921
-483
| -9% | -$31.5K |
|
971
HSBC
HSBC
$355B
| $334K | ﹤0.01% |
10,239
+2,791
| +37% | +$90.5K |
|
972
Manulife Financial
MFC
$73.9B
| $332K | ﹤0.01% |
19,217
-216
| -1% | -$4.08K |
|
973
Varonis Systems
VRNS
$5.31B
| $330K | ﹤0.01% |
11,262
-22
| -0.2% | -$818 |
|
974
iShares ESG Aware MSCI EM ETF
ESGE
$6.43B
| $329K | ﹤0.01% |
10,205
-12,845
| -56% | -$436K |
|
975
Ball Corp
BALL
$17.8B
| $328K | ﹤0.01% |
4,772
+345
| +8% | +$26.2K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q2 2022 Portfolio in Review
As of Q2 2022, Glenmede Trust held 1,420 positions worth $17.1B, down 16% from $20.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Glenmede Trust's Q2 2022 filing shows 91 new, 417 increased, 597 reduced and 121 closed positions. Its largest new stake was Pinterest: 974,820 shares worth $17.7M. The largest sale was Accenture, an estimated $53M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- Glenmede Trust's largest Q2 2022 buy was Pinterest: 974,820 shares worth $17.7M.
- Glenmede Trust added most to Vanguard Total Stock Market ETF in Q2 2022, an estimated $69.4M increase.
- Glenmede Trust's biggest Q2 2022 reduction was Accenture, cutting an estimated $53M.
- Glenmede Trust fully exited Ovintiv in Q2 2022, selling an estimated $35M.
- Glenmede Trust's ten largest holdings make up 20% of its $17.1B portfolio in Q2 2022.
- Glenmede Trust opened 91 new positions and closed 121 in Q2 2022.
- Glenmede Trust's portfolio value fell 16% quarter-over-quarter to $17.1B.
Based on Glenmede Trust's 13F filing for Q2 2022, filed 15 Aug 2022.